Solid biosciences to present at barclays global healthcare conference

Charlestown, mass., march 07, 2023 (globe newswire) -- solid biosciences inc. (nasdaq: sldb), a life sciences company developing genetic medicines for neuromuscular and cardiac diseases, today announced that bo cumbo, president and chief executive officer, will present at the barclays global healthcare conference on tuesday, march 14, 2023, at 3:35 pm et.
SLDB Ratings Summary
SLDB Quant Ranking